Status:

ACTIVE_NOT_RECRUITING

New Approaches in MRI at 3T Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients

Lead Sponsor:

Institut National de la Santé Et de la Recherche Médicale, France

Conditions:

Parkinson Disease

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a validated procedure, used in many French and international centers for the treatment of severe forms of Parkinson's disease (PD). The...

Detailed Description

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a validated procedure, used in many French and international centers for the treatment of severe forms of Parkinson's disease (PD). The...

Eligibility Criteria

Inclusion

  • Diagnosis of idiopathic Parkinson's disease (according to the criteria of the "United Kingdom Parkinson's Disease Society Brain Bank";
  • Age between 18 and 70 years
  • motor complications in the form of fluctuations in motor state or induced dyskinesias dopaminergic therapy, despite optimal medical treatment;
  • Excellent responsiveness to levodopa (improved motor UPDRS score of higher than 50% during the acute test with levodopa)
  • People who voluntarily accepted and intelligently participate in the study (signing a written consent)
  • Patient receiving social health insurance

Exclusion

  • Patients carry an apomorphine pump used in single and continuous treatment;
  • scalable psychiatric pathology;
  • Dementia (MMS \<24/30);
  • Existence of against-indications to MRI (cardiac or neural stimulator, ferromagnetic surgical clips, implants and metal objects, intraocular foreign bodies, pregnancy, claustrophobia).
  • Persons under guardianship, trusteeship or any other administrative or judicial deprivation of rights and freedom

Key Trial Info

Start Date :

October 12 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 7 2025

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT02800460

Start Date

October 12 2016

End Date

December 7 2025

Last Update

August 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

GHPS

Paris, Île-de-France Region, France, 75651

New Approaches in MRI at 3T Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients | DecenTrialz